文献速递乳腺MR乳腺X线

乳腺癌个人史女性的监测性乳腺MRI与乳腺X线摄影比较

Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer.
PubMed 文献 · Radiology · 2019-06-04

该观察性队列研究纳入13266例有0–III期乳腺癌个人史的女性,比较监测性乳腺MRI与单纯乳腺X线摄影的性能。乳腺MRI与更高的活检率(OR 2.2)和癌检出率(OR 1.7)相关,但敏感度和间期癌率无显著差异。比较两种监测方式的性能时必须考虑患者特征。

要点

  • 乳腺MRI组癌检出率10.8/1000次检查,单纯乳腺X线摄影组8.2/1000次检查。
  • 乳腺MRI组活检率10.1%,单纯乳腺X线摄影组4.0%。
  • 多变量模型中乳腺MRI活检率OR 2.2、癌检出率OR 1.7,敏感度和间期癌率无显著差异。

核心结论

  • 比较监测性乳腺MRI与乳腺X线摄影的性能必须考虑患者特征;乳腺MRI导致更高的活检率和癌检出率,但敏感度或间期癌与乳腺X线摄影相比无显著差异。

研究设计与样本

  • 观察性队列研究,使用前瞻性收集的数据,纳入13266例18岁及以上(平均年龄60岁±13)有0–III期乳腺癌个人史的女性,2005年至2012年在Breast Cancer Surveillance Consortium接受33938次乳腺X线摄影检查和2506次乳腺MRI检查;分为单纯乳腺X线摄影组(n=11745)和乳腺MRI组(n=1521);以检查当日评估及影像后1年内发生第二乳腺癌事件计算性能指标;采用逻辑回归比较乳腺MRI与单纯乳腺X线摄影的性能,校正女性、检查及原发乳腺癌特征;按检查次数进行分析。

诊断标准与关键数值

  • 乳腺MRI组癌检出率10.8/1000次检查(95%CI 6.7, 14.8),单纯乳腺X线摄影组8.2/1000次检查(95%CI 7.3, 9.2)。
  • 乳腺MRI组敏感度61.4%(27/44;95%CI 46.5%, 76.2%),单纯乳腺X线摄影组70.3%(279/397;95%CI 65.8%, 74.8%)。
  • 乳腺MRI组活检率10.1%(253/2506;95%CI 8.9%, 11.3%),单纯乳腺X线摄影组4.0%(1343/33938;95%CI 3.7%, 4.2%)。
  • 多变量模型中乳腺MRI较单纯乳腺X线摄影活检率更高(OR 2.2;95%CI 1.9, 2.7;P < .001),癌检出率更高(OR 1.7;95%CI 1.1, 2.7;P = .03)。
  • 多变量模型中乳腺MRI与单纯乳腺X线摄影的敏感度无差异(OR 1.1;95%CI 0.4, 2.9;P = .84),间期癌率无差异(OR 1.1;95%CI 0.6, 2.2;P = .70)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background There is lack of consensus regarding the use of breast MRI for routine surveillance for second breast cancer events in women with a personal history of breast cancer. Purpose To compare performance of surveillance mammography with breast MRI. Materials and Methods This observational cohort study used prospectively collected data and included 13 266 women age 18 years and older (mean age, 60 years ± 13) with stage 0-III breast cancer who underwent 33 938 mammographic examinations and 2506 breast MRI examinations from 2005 to 2012 in the Breast Cancer Surveillance Consortium. Women were categorized into two groups: mammography alone (n = 11 745) or breast MRI (n = 1521). Performance measures were calculated by using end-of-day assessment and occurrence of second breast cancer events within 1 year of imaging. Logistic regression was used to compare performance for breast MRI versus mammography alone, adjusting for women, examination, and primary breast cancer characteristics. Analysis was conducted on a per-examination basis. Results Breast MRI was associated with younger age at diagnosis, chemotherapy, and higher education and income. Raw performance measures for breast MRI versus mammography were as follows, respectively: cancer detection rates, 10.8 (95% confidence interval [CI]: 6.7, 14.8) versus 8.2 (95% CI: 7.3, 9.2) per 1000 examinations; sensitivity, 61.4% (27 of 44; 95% CI: 46.5%, 76.2%) versus 70.3% (279 of 397; 95% CI: 65.8%, 74.8%); and biopsy rate, 10.1% (253 of 2506; 95% CI: 8.9%, 11.3%) versus 4.0% (1343 of 33 938; 95% CI: 3.7%, 4.2%). In multivariable models, breast MRI was associated with higher biopsy rate (odds ratio [OR], 2.2; 95% CI: 1.9, 2.7; P < .001) and cancer detection rate (OR, 1.7; 95% CI: 1.1, 2.7; P = .03) than mammography alone. However, there were no differences in sensitivity (OR, 1.1; 95% CI: 0.4, 2.9; P = .84) or interval cancer rate (OR, 1.1; 95% CI: 0.6, 2.2; P = .70). Conclusion Comparison of the performance of surveillance breast MRI with mammography must account for patient characteristics. Whereas breast MRI leads to higher biopsy and cancer detection rates, there were no significant differences in sensitivity or interval cancers compared with mammography. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Newell in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Wernli KJ, Ichikawa L, Kerlikowske K, et al. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019. PMID: 31161975. doi:10.1148/radiol.2019182475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。